E&Y 2005 Colorado Bio Snapshot

According to Ernst & Young here are some biotech industry metrics for the state of Colorado.

Colorado, which ranks 14th on the accounting firm's list of biotech regions, was home to seven public biotech companies in 2005, the same as in 2004.

E&Y found growth in other areas:

- Market cap of public companies grew 9% from '04, to $2.4B
- Revenues rose 59%, to $281 million.
- Total assets were up 19%, to $862 million.
- Cash and short-term investments rose 26%, to $621 million.

The only negative was that the biotech companies posted net income of $132 million in 2005, that's a drop of 24 percent from a year earlier.